XML 58 R43.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model.
Years Ended December 31,
202220212020
Weighted average grant date fair value****$38.45
Expected term (in years)****3.8
Expected volatility****86.4%
Annual risk-free rate of return****0.1%
Dividend yield****—%
**    No stock options were granted during the years ended December 31, 2022 and 2021
Summary of the Components of Total Stock-Based Compensation Expense
The following table summarizes the components of total stock-based compensation expense included in the consolidated statements of operations for the periods presented:
Years Ended December 31,
202220212020
(In thousands)
Cost of revenues$13,097 $7,366 $3,759 
Research and development69,082 33,927 12,701 
Sales and marketing78,819 37,434 11,548 
General and administrative55,804 35,559 14,495 
Total$216,802 $114,286 $42,503 
Income tax benefit included in the provision for income taxes$45,066 $97,129 $61,389 
Summary of Stock-Based Compensation Associated with Each Type of Award
The following table summarizes the various types of stock-based compensation expense for the periods presented:
Years Ended December 31,
202220212020
(In thousands)
Stock options, RSUs and PSUs$200,295 $110,142 $39,841 
Employee stock purchase plan5,475 4,144 2,662 
Post combination expense accrual (Accrued liabilities)11,032 — — 
Total$216,802 $114,286 $42,503 
Summary of Stock Option Activity
The following table summarizes stock option activity:
Number of
Shares
Outstanding
Weighted-
Average
Exercise Price
per Share
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20194,097 $2.18 
Granted11 64.17 
Exercised(1,494)2.74 $114,089 
Canceled(82)6.94 
Outstanding at December 31, 20202,532 $1.96 
Granted— — 
Exercised(267)2.44 $42,091 
Canceled(1)0.83 
Outstanding at December 31, 20212,264 $1.90 
Granted— — 
Exercised(799)2.02 $197,334 
Canceled(1)8.82 
Outstanding at December 31, 20221,464 $1.83 2.0$385,125 
Vested and expected to vest at December 31, 20221,464 $1.83 2.0$385,125 
Exercisable at December 31, 20221,464 $1.83 2.0$385,125 
(1)    The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise. The intrinsic value of options outstanding, vested and expected to vest, and exercisable as of December 31, 2022 is based on the closing price of the last trading day during the period ended December 31, 2022. The Company’s stock fair value used in this computation was $264.96 per share.
Summary of Stock Option Outstanding
The following table summarizes information about stock options outstanding at December 31, 2022:
Options OutstandingOptions Exercisable
Range of Exercise PricesNumber of
Shares
Weighted-
Average
Remaining
Life
Weighted-
Average
Exercise
Price
Number of
Shares
Weighted-
Average
Exercise
Price
(In thousands)(Years)(In thousands)
$0.70 —– $1.11
422 2.5$0.90 422 $0.90 
$1.29 —– $1.29
935 1.71.29 935 1.29 
$1.31 —– $5.53
80 2.14.28 80 4.28 
$14.58 —– $14.58
20 3.314.58 20 14.58 
$64.17 —– $64.17
4.364.17 64.17 
Total1,464 2.0$1.83 1,464 $1.83 
Summary of Restricted Stock Unit Activity
The following table summarizes RSU activity:
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20194,263 $7.19 
Granted1,550 55.66 
Vested(2,085)7.26 $125,578 
Canceled(140)19.47 
Outstanding at December 31, 20203,588 $27.61 
Granted1,301 179.88 
Vested(1,979)20.47 $364,665 
Canceled(124)88.50 
Outstanding at December 31, 20212,786 $100.73 
Granted1,159 228.88 
Vested(1,500)72.87 $321,274 
Canceled(192)150.02 
Outstanding at December 31, 20222,253 $181.01 1.2$597,032 
Expected to vest at December 31, 20222,253 $181.01 1.2$596,995 
(1)    The intrinsic value of RSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of RSUs outstanding and expected to vest as of December 31, 2022 is based on the closing price of the last trading day during the period ended December 31, 2022. The Company’s stock fair value used in this computation was $264.96 per share.
Share-based Compensation, Performance Shares Award Outstanding Activity
The following summarizes PSU activity:
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 2019955 $9.83 
Granted989 31.12 
Vested(1,450)10.20 $52,144 
Canceled— — 
Outstanding at December 31, 2020494 $51.10 
Granted715 131.60 
Vested(494)59.19 $91,803 
Canceled(270)52.75 
Outstanding at December 31, 2021445 $169.82 
Granted413 195.29 
Vested(303)168.88 $51,393 
Canceled(179)171.32 
Outstanding at December 31, 2022376 $197.82 0.2$99,726 
Expected to vest at December 31, 2022376 $197.82 0.2$99,726 
(1)    The intrinsic value of PSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of PSUs outstanding and expected to vest as of December 31, 2022 is based on the closing price of the last trading day during the period ended December 31, 2022. The Company’s stock fair value used in this computation was $264.96 per share.
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity
A summary of ESPP activity for the years presented is as follows: (in thousands, except per share data):
Years Ended December 31,
202220212020
Proceeds from common stock issued under ESPP$9,570 $6,832 $4,304 
Shares of common stock issued90 235 347 
Weighted-average price per share$106.32 $29.12 $12.41